Bergamottin treatment of MDA-MB-231 breast cancer proliferation has caused a significant reduction of phosphorylation, nuclear translocation, expression, and DNA binding activity of signal transducers and activator of transcription 3 (STAT3) [113]. This evidence concerns the gene STAT3 and breast carcinoma.